In the presented case, hearing loss was observed ten years after the completion of chemotherapy, and it concerned high frequencies in the 6,000 to 16,000 Hz range for both ears
However, human trials of a GPR119 agonist failed to significantly increase GLP-1 levels(Nunez et al., 2014), complicating the interpretation of previous results from model systems
Triple hormone receptor agonist Retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
There is a body of research that glutamine supplementation during hospitalization or the recovery period could help aid the healing process, prevent the risk of infections, and prevent additional injury to the organs
The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD
Emotionally, mentally and physically, I am a completely different person and I love it